ChemicalBook >> CAS DataBase List >>Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)-
Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)-
- CAS No.
- 327164-11-4
- Chemical Name:
- Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)-
- Synonyms
- Caprazamycin;Caprazamycin B;Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)-;(2S,5S,6S)-2-((S)-(((2S,3R,4S,5R)-5-(Aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl)oxy)((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-1,4-dimethyl-6-(((S)-14-methyl-3-(((S)-3-methyl-5-oxo-5-(((2S,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)pentanoyl)oxy)pentadecanoyl)oxy)-3-oxo-1,4-diazepane-5-carboxylic acid
- CBNumber:
- CB39038096
- Molecular Formula:
- C53H87N5O22
- Molecular Weight:
- 1146.29
- MDL Number:
- MOL File:
- 327164-11-4.mol
Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)- Properties
Density | 1.34±0.1 g/cm3(Predicted) |
---|---|
pka | 2.05±0.60(Predicted) |
Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)- Preparation Products And Raw materials
Raw materials
Preparation Products
Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)- Suppliers
Global( 3)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 | 2853530910@QQ.com | China | 8011 | 62 |
Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 62075 | 58 |
SHANG HAI WEI LING BIOTECHNOLOGY CO.,LTD | 13917490980; 13917490980 | 81939905@qq.com | China | 352 | 58 |
Supplier | Advantage |
---|---|
ShangHai Biochempartner Co.,Ltd | 62 |
Bide Pharmatech Ltd. | 58 |
SHANG HAI WEI LING BIOTECHNOLOGY CO.,LTD | 58 |
Uridine, 5'-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-5'-C-[(2S,5S,6S)-5-carboxy-6-[[(3S)-3-[[(3S)-5-[(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyl)oxy]-3-methyl-1,5-dioxopentyl]oxy]-14-methyl-1-oxopentadecyl]oxy]hexahydro-1,4-dimethyl-3-oxo-1H-1,4-diazepin-2-yl]-, (5'S)-
Caprazamycin B
Caprazamycin
(2S,5S,6S)-2-((S)-(((2S,3R,4S,5R)-5-(Aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yl)oxy)((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)-1,4-dimethyl-6-(((S)-14-methyl-3-(((S)-3-methyl-5-oxo-5-(((2S,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)pentanoyl)oxy)pentadecanoyl)oxy)-3-oxo-1,4-diazepane-5-carboxylic acid
327164-11-4
C53H87N5O22